BMJ  2006;332:335-339 (11 February), doi:10.1136/bmj.38701.399942.63 (published 18 January 2006)

Research

Case reports of suspected adverse drug reactions—systematic literature survey of follow-up

¹ School of Medicine, Health Policy, and Practice, University of East Anglia, Norwich NR4 7TJ, ² Department of Clinical Pharmacology, University of Oxford, Radcliffe Infirmary, Oxford OX2 6HE

Abstract

Objective To determine whether anecdotal reports of suspected adverse drug reactions are valuable early warning signals.

Design Systematic literature survey

Data sources We evaluated all case reports of adverse drug reactions published in 1997 in five medical journals. Reports were excluded if the adverse reaction had previously been described in earlier publications and was already listed in the product information of the drug reference source (the British National Formulary (BNF) or the Medicines Compendium). We used the Web of Knowledge Citation Index and Medline for 2003 to identify follow-up studies.

Main outcome measures Primary: the number of suspected adverse reactions subjected to formal validation studies and the findings of these studies. Secondary: the number of instances in which the warning from the case report was incorporated into the product information.

Results We evaluated 63 suspected adverse reactions and found that most (52/63, 83%) had not yet been subjected to further detailed evaluation. Data from controlled studies that supported the postulated link between the drug and the adverse event were available in only three cases. Of the 48 agents listed in the drug reference sources, details of the suspected reaction were subsequently added to the Medicines Compendium in 15 instances, and to the BNF in seven instances. In each case, only one reaction had been confirmed.

Conclusions Published case reports of suspected adverse reactions are of limited value as suspicions are seldom subjected to confirmatory investigation. Furthermore, these alerts are not incorporated into drug reference sources in a systematic manner.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Anecdotes that provide definitive evidence

Jeffrey K Aronson and Manfred Hauben
BMJ 2006 333: 1267-1269. [Full Text] [PDF]

Communicating information about drug safety

R E Ferner and J K Aronson
BMJ 2006 333: 143-145. [Full Text] [PDF]

Who will fund hypothesis testing studies?

Mira Harrison-Woolrych
BMJ 2006 332: 666-667. [Extract] [Full Text]

Case reports of suspected adverse drug reactions: Case reports were dismissed too quickly

Jan P Vandenbroucke
BMJ 2006 332: 488. [Extract] [Full Text] [PDF]

Case reports of suspected adverse drug reactions: Case reports generate signals efficiently

Stefan Russmann
BMJ 2006 332: 488. [Extract] [Full Text]

Case reports of suspected adverse drug reactions are of limited value
BMJ 2006 332: 0. [Full Text]

Detection, verification, and quantification of adverse drug reactions

Bruno HCh Stricker and Bruce M Psaty
BMJ 2004 329: 44-47. [Extract] [Full Text] [PDF]

Assessing the benefit-harm balance at the bedside

Yoon Kong Loke
BMJ 2004 329: 7-8. [Extract] [Full Text] [PDF]

Assessing the quality of research

Paul Glasziou, Jan Vandenbroucke, and Iain Chalmers
BMJ 2004 328: 39-41. [Extract] [Full Text] [PDF]

Anecdotes as evidence

Jeffrey K Aronson
BMJ 2003 326: 1346. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Loke, Y. K. MBBS MD, Singh, S. MD MPH, Furberg, C. D. MD PhD (2009). Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ 180: 32-39 [Abstract] [Full text]  
• Aronson, J. K, Hauben, M. (2006). Anecdotes that provide definitive evidence. BMJ 333: 1267-1269 [Full text]  
• Huang, H.-Y., Caballero, B., Chang, S., Alberg, A. J., Semba, R. D., Schneyer, C. R., Wilson, R. F., Cheng, T.-Y., Vassy, J., Prokopowicz, G., Barnes, G. J. II, Bass, E. B. (2006). The Efficacy and Safety of Multivitamin and Mineral Supplement Use To Prevent Cancer and Chronic Disease in Adults: A Systematic Review for a National Institutes of Health State-of-the-Science Conference. ANN INTERN MED 145: 372-385 [Abstract] [Full text]  
• Ferner, R E, Aronson, J K (2006). Communicating information about drug safety.. BMJ 333: 143-145 [Full text]  
• Harrison-Woolrych, M. (2006). Who will fund hypothesis testing studies?. BMJ 332: 666-667 [Full text]  
• (2006). Anecdotal Reports of Adverse Drug Reactions. JWatch General 2006: 7-7 [Full text]  
• Vandenbroucke, J. P (2006). Case reports of suspected adverse drug reactions: case reports were dismissed too quickly.. BMJ 332: 488-488 [Full text]  
• Russmann, S. (2006). Case reports of suspected adverse drug reactions: case reports generate signals efficiently.. BMJ 332: 488-488 [Full text]  

Rapid Responses:

Read all Rapid Responses

Case reports too quickly dismissed

Jan P Vandenbroucke
bmj.com, 29 Jan 2006 [Full text]

Case reports of suspected adverse drug reactions do what they are supposed to do: they efficiently generate signals

Stefan Russmann
bmj.com, 11 Feb 2006 [Full text]

Even a ‘Lesson of the week’ in the BMJ did NOT make much of a difference

George I. Varughese MRCPI; MRCP(U.K.), et al.
bmj.com, 11 Feb 2006 [Full text]

Case reports vital for pharmacovigilance

Douglas E. Ball
bmj.com, 11 Feb 2006 [Full text]

Not always so quick

Christopher Anton
bmj.com, 14 Feb 2006 [Full text]

The importance of anecdotal case reports should not be underestimated

Martin H Goldman
bmj.com, 17 Feb 2006 [Full text]

Case reports of suspected adverse drug reactions

Geoffrey Richard Venning
bmj.com, 20 Feb 2006 [Full text]

Lack of follow-up negates value of case reports

Yoon K LOKE, et al.
bmj.com, 27 Feb 2006 [Full text]

Online poll

Find out more on doc2doc >>